Anca Askanase

Anca Askanase

UNVERIFIED PROFILE

Are you Anca Askanase?   Register this Author

Register author
Anca Askanase

Anca Askanase

Publications by authors named "Anca Askanase"

Are you Anca Askanase?   Register this Author

56Publications

1281Reads

-Profile Views

Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.

J Rheumatol 2019 May 15;46(5):492-500. Epub 2019 Jan 15.

From the Rheumatology/Division of Neuro and Inflammation Sciences, Department of Clinical and Experimental Medicine, Linköping University, Linköping; Department of Medicine, Unit of Rheumatology, Karolinska Institutet and Karolinska University Hospital, Stockholm; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Lund; Unit for Clinical Therapy Research (ClinTRID), Karolinska University, Stockholm, Sweden; Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario; Division of Rheumatology, Centre Hospitalier Universitaire (CHU) de Québec - Université Laval, Quebec City, Quebec; Division of Rheumatology, Cumming School of Medicine - University of Calgary, Calgary, Alberta; Division of Rheumatology, Department of Medicine, McGill University Health Centre, Montreal, Quebec; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia; Department of Medicine and Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham; Centre for Rheumatology Research, University College, London; Lupus Research Unit, The Rayne Institute, St. Thomas' Hospital, King's College London School of Medicine, London; Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, The University of Manchester and UK National Institute for Health Research (NIHR) Manchester Biomedical Research Centre, Manchester University Foundation Trust, Manchester, UK; Cedars-Sinai/David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, California; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Department of Medicine, State University of New York (SUNY) Downstate Medical Center, Brooklyn, New York; Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama; Department of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Feinstein Institute for Medical Research, Manhasset, New York; Division of Rheumatology and Immunology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina; Autoimmunity Institute, Allegheny Health Network, Pittsburgh, Pennsylvania; Northwestern University and Feinberg School of Medicine, Chicago, Illinois; Division of Rheumatology, Emory University School of Medicine, Atlanta, Georgia; University of California San Diego School of Medicine, La Jolla, California; Division of Rheumatology, Medical University of South Carolina, Charleston, South Carolina; Division of Rheumatology, Columbia University Medical Center, New York, New York, USA; Department of Rheumatology, Center for Rheumatology Research Fossvogur Landspitali University Hospital, Reyjkavik, Iceland; Autoimmune Disease Unit, Department of Internal Medicine, Hospital Universitario Cruces, BioCruces Health Research Institute, University of the Basque Country, Barakaldo; Josep Font Autoimmune Diseases Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain; Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Copenhagen Lupus and Vasculitis Clinic, Centre for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Rheumatology, Kantousspital, Schaffhausen, Switzerland.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.180713
Publisher Site
http://dx.doi.org/10.3899/jrheum.180713DOI Listing
May 2019

Measuring disease activity in SLE is an ongoing struggle.

Nat Rev Rheumatol 2019 Apr;15(4):194-195

Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41584-019-0190-1DOI Listing
April 2019

Construction of a frailty index as a novel health measure in systemic lupus erythematosus.

J Rheumatol 2019 Apr 15. Epub 2019 Apr 15.

Department of Medicine, Division of Rheumatology, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Community Health & Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada; Division of Geriatric Medicine, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea;Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Instituto Nacional de Ciencias Medicas y Nutrición, Mexico City, Mexico; Cedars-Sinai/David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Divisions of Rheumatology and Clinical Epidemiology, Department of Medicine, McGill University, Montreal, Quebec, Canada; Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, USA; Division of Rheumatology, CHU de Québec et Université Laval, Quebec City, Canada; Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, ON, Canada; Arthritis Research UK Epidemiology Unit, Faculty of Biology Medicine and Health, Manchester Academic Health Sciences Center, The University of Manchester, and NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Center Manchester, UK; Center for Rheumatology, Department of Medicine, University College London, UK; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, King's College London School of Medicine, UK, London, UK; Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, USA; Northwestern University and Feinberg School of Medicine, Chicago, IL, USA; Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, PA, USA; Lanarkshire Center for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland UK; Feinstein Institute for Medical Research, Manhasset, NY, USA; Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain; Emory University School of Medicine, Division of Rheumatology, Atlanta, Georgia, USA Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Unit for clinical therapy research (ClinTRID), Karolinska Institute, Stockholm, Sweden; Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund, Sweden. Josep Font Autoimmune Diseases Laboratory, IDIBAPS, Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain; Medical University of South Carolina, Charleston, South Carolina, USA; UCSD School of Medicine, La Jolla, CA, USA; Copenhagen Lupus and Vasculitis Clinic, 4242, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; University of Manitoba, Winnipeg, Manitoba, Canada; Hospital for Joint Diseases, NYU, Seligman Center for Advanced Therapeutics, New York NY; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada. Funding for this work was provided by the Nova Scotia Health Authority Research Fund. Dr. Sang-Cheol Bae's work was supported in part by NRF-2017M3A9B4050335, Republic of Korea. Dr. Caroline Gordon's work was supported by Lupus UK and the NIHR /Wellcome Trust Clinical Research Facility. The Montreal General Hospital Lupus Clinic is partially supported by the Singer Family Fund for Lupus Research. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Paul R. Fortin presently holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases at Université Laval, and part of this work was done while he was still holding a Distinguished Senior Investigator of The Arthritis Society. Dr. Bruce is a National Institute for Health Research (NIHR) Senior Investigator and is supported by Arthritis Research UK, the NIHR Manchester Biomedical Centre and the NIHR/Wellcome Trust Manchester Clinical Research Facility. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. Dr Isenberg and Dr Rahman are supported by and supported by the National Institute for Health, Research University College London Hospitals Biomedical Research Center. The Hopkins Lupus Cohort is supported by the NIH (grant AR43727 and 69572). Dr. Mary Anne Dooley's work was supported by the NIH (grant RR00046). Dr. Ramsey-Goldman's work was supported by the NIH (grants 5UL1TR001422-02, formerly 8UL1TR000150 and UL-1RR-025741, K24-AR-02318, and P60AR064464 formerly P60-AR- 48098). Dr. Ruiz-Irastorza is supported by the Department of Education, Universities and Research of the Basque Government. Dr. Soren Jacobsen is supported by the Danish Rheumatism Association (A3865) and the Novo Nordisk Foundation (A05990). Dr. John G. Hanly is supported by the Canadian Institutes of Health Research (grant MOP-88526). Address Correspondence to: Dr. John G Hanly, Division of Rheumatology, Nova Scotia Rehabilitation Centre (2nd Floor), 1341 Summer Street, Halifax, Nova Scotia, Canada, B3H 4K4.Email:

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.181338
Publisher Site
http://dx.doi.org/10.3899/jrheum.181338DOI Listing
April 2019

Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines.

Arthritis Res Ther 2018 07 5;20(1):133. Epub 2018 Jul 5.

Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Bulfinch 165, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-018-1634-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034317PMC
July 2018

Myocarditis in systemic lupus erythematosus diagnosed by F-fluorodeoxyglucose positron emission tomography.

Lupus Sci Med 2018 12;5(1):e000265. Epub 2018 Jul 12.

Division of Rheumatology, Columbia University College of Physicians and Surgeons, New York Presbyterian Hospital, New York City, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/lupus-2018-000265DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069920PMC
July 2018

Treatment Satisfaction in Systemic Lupus Erythematosus: Development of a Patient-Reported Outcome Measure.

J Clin Rheumatol 2017 Mar;23(2):94-101

From the *Health Outcomes Solutions, Winter Park, FL; †GlaxoSmithKline, Philadelphia, PA; ‡GlaxoSmithKline, London, UK; and §Columbia University Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00124743-201703000-0000
Publisher Site
http://dx.doi.org/10.1097/RHU.0000000000000495DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671785PMC
March 2017

Use of Glucuronidated Mycophenolic Acid Levels for Therapeutic Monitoring in Pediatric Lupus Nephritis Patients.

J Clin Rheumatol 2016 Mar;22(2):75-9

From the *Division of Pediatric Rheumatology, Cohen Children's Medical Center, Lake Success, NY; †Chicago College of Pharmacy, Midwestern University, Downers Grove, IL; and ‡Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian, Columbia University Medical Center; §College of Pharmacy and Health Professions, St John's University, Jamaica; ∥Division of Rheumatology, New York-Presbyterian Hospital, Columbia University Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RHU.0000000000000357DOI Listing
March 2016

Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices.

J Rheumatol 2015 Dec 1;42(12):2288-95. Epub 2015 Nov 1.

From the Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; New York University Langone Medical Center; Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center, New York; Hofstra North Shore-LIJ School of Medicine, Hempstead, New York; Medical University of South Carolina, Charleston, South Carolina; Temple University School of Medicine, Philadelphia, Pennsylvania; Johns Hopkins University School of Medicine, Baltimore, Maryland; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Karolinska University Hospital, Stockholm, Sweden; Cedars-Sinai Medical Center, Los Angeles, California, USA.J.S. Hui-Yuen, MD, MSc, Fellow, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; A. Reddy, BSc, Research Assistant, New York University Langone Medical Center; J. Taylor, MD, Pediatric Resident, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; X. Li, BSc, Research Assistant, Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center; A.H. Eichenfield, MD, Assistant Professor, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; L.M. Bermudez, MD, Fellow, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; A.J. Starr, MD, Assistant Professor, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; L.F. Imundo, MD, Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center; J. Buyon, MD, Professor, New York University Langone Medical

View Article

Download full-text PDF

Source
http://www.jrheum.org/cgi/doi/10.3899/jrheum.150470
Publisher Site
http://dx.doi.org/10.3899/jrheum.150470DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031077PMC
December 2015

Belimumab in systemic lupus erythematosus: a perspective review.

Ther Adv Musculoskelet Dis 2015 Aug;7(4):115-21

Division of Adult Rheumatology, New York Presbyterian Hospital, Columbia University Medical Center, 630 W 168th St, P&S Building, 10th floor, New York, NY 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1759720X15588514DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530384PMC
August 2015

Post-marketing experiences with belimumab in the treatment of SLE patients.

Rheum Dis Clin North Am 2014 Aug 3;40(3):507-17, viii. Epub 2014 Jun 3.

GlaxoSmithKline, 5 Crescent Drive, Philadelphia, PA 10112, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rdc.2014.04.007DOI Listing
August 2014

Systemic lupus erythematosus: an overview.

Soc Work Health Care 2012 ;51(7):576-86

Department of Rheumatology, NYU School of Medicine, New York, New York 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00981389.2012.683369DOI Listing
January 2013

Belimumab and the clinical data.

Curr Rheumatol Rep 2012 Aug;14(4):310-7

Department of Rheumatology, New York University School of Medicine, Seligman Center for Advanced Therapeutics, 333 East 38th Street, 4th Floor, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11926-012-0264-4DOI Listing
August 2012

Treatment of lupus nephritis.

Curr Rheumatol Rep 2011 Aug;13(4):283-90

Department of Rheumatology, Seligman Center for Advanced Therapeutics, New York University School of Medicine, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11926-011-0187-5
Publisher Site
http://dx.doi.org/10.1007/s11926-011-0187-5DOI Listing
August 2011

Quantitative data for care of patients with systemic lupus erythematosus in usual clinical settings: a patient Multidimensional Health Assessment Questionnaire and physician estimate of noninflammatory symptoms.

J Rheumatol 2011 Jul 1;38(7):1309-16. Epub 2011 Apr 1.

Department of Medicine, Division of Rheumatology, New York University School of Medicine and NYU Hospital for Joint Diseases, New York, NY 10003, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.101091DOI Listing
July 2011

Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart block.

Arthritis Rheum 2010 Apr;62(4):1153-7

New York University School of Medicine, New York, New York 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.27333DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919829PMC
April 2010

A multi-dimensional health assessment questionnaire (MDHAQ) and routine assessment of patient index data (RAPID3) scores are informative in patients with all rheumatic diseases.

Rheum Dis Clin North Am 2009 Nov;35(4):819-27, x

Division of Rheumatology, Department of Medicine, New York University School of Medicine and NYU Hospital for Joint Diseases, Room 1608, 301 East 17th Street, New York, NY 10003, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rdc.2009.10.017DOI Listing
November 2009

Use of pharmacogenetics, enzymatic phenotyping, and metabolite monitoring to guide treatment with azathioprine in patients with systemic lupus erythematosus.

J Rheumatol 2009 Jan;36(1):89-95

Department of Medicine, Hospital for Joint Diseases, Division of Rheumatology, New York University School of Medicine, 560 First Avenue, TCH-407, New York, NY 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.070968DOI Listing
January 2009

Estrogen therapy in systemic lupus erythematosus.

Authors:
Anca D Askanase

Treat Endocrinol 2004 ;3(1):19-26

Department of Reumatology, Hospital for Joint Diseases, New York University School of Medicine, New York, New York 10003, USA.

View Article

Download full-text PDF

Source
March 2005

Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block.

Arthritis Rheum 2004 Jan;50(1):173-82

Hospital for Joint Diseases, New York University School of Medicine, New York, New York 10003, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.11430DOI Listing
January 2004

Cardiac 5-HT(4) serotoninergic receptors, 52kD SSA/Ro and autoimmune-associated congenital heart block.

J Autoimmun 2002 Aug-Sep;19(1-2):79-86

Department of Rheumatology, Hospital for Joint Diseases, New York University School of Medicine, New York, NY 10003, USA.

View Article

Download full-text PDF

Source
April 2003

Long-term followup of children with neonatal lupus and their unaffected siblings.

Arthritis Rheum 2002 Sep;46(9):2377-83

Hospital for Joint Diseases, New York University School of Medicine, New York, New York 10003, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.10638DOI Listing
September 2002

Transdifferentiation of cardiac fibroblasts, a fetal factor in anti-SSA/Ro-SSB/La antibody-mediated congenital heart block.

J Immunol 2002 Aug;169(4):2156-63

Department of Rheumatology, Hospital for Joint Diseases, New York University School of Medicine, New York, NY 10003, USA.

View Article

Download full-text PDF

Source
http://www.jimmunol.org/content/169/4/2156.full.pdf
Web Search
http://dx.doi.org/10.4049/jimmunol.169.4.2156DOI Listing
August 2002

Reproductive health in SLE.

Best Pract Res Clin Rheumatol 2002 Apr;16(2):265-80

Clinical Medicine, New York University School of Medicine, Lupus Clinic, Hospital for Joint Diseases, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/berh.2002.0225DOI Listing
April 2002